Induction of Salivary Nerve Growth Factor by Yogic Breathing: A Randomized Controlled Trial

por BALASUBRAMANIAN, SUNDARAVADIVEL, MINTZER, JACOBO E., WAHLQUIST, AMY E.
Publicado en Int Psychogeriatr (2014)

Apolipoprotein E and Gray Matter Volume Loss in Patients with Mild Cognitive Impairment and Alzheimer Disease

por Spampinato, Maria Vittoria, Rumboldt, Zoran, Hosker, Robert J., Mintzer, Jacobo E.
Publicado en Radiology (2011)

Alzheimer's Disease in the Family Practice Setting: Assessment of a Screening Tool

por Carter, Rickey E., Rose, Del A., Palesch, Yuko Y., Mintzer, Jacobo E.
Publicado 2004

Designing a trial to evaluate potential treatments for apathy in dementia: the Apathy in Dementia Methylphenidate trial (ADMET)

por Drye, Lea T., Scherer, Roberta W., Lanctôt, Krista L., Rosenberg, Paul B., Herrmann, Nathan, Bachman, David, Mintzer, Jacobo E.
Publicado 2013

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer's Disease: A Randomized, Placebo-Controlled Trial

por Rosenberg, Paul B., Lanctôt, Krista L., Drye, Lea T., Herrmann, Nathan, Scherer, Roberta W., Bachman, David L., Mintzer, Jacobo E.
Publicado 2013

Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo controlled trial

por Lanctôt, Krista L., Chau, Sarah A., Herrmann, Nathan, Drye, Lea T., Rosenberg, Paul B., Scherer, Roberta W., Black, Sandra E., Vaidya, Vijay, Bachman, David L., Mintzer, Jacobo E.
Publicado 2013

A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation

por Akil, Ayman, Bies, Robert R., Pollock, Bruce G., Avramopoulos, Dimitrios, Devanand, D. P., Mintzer, Jacobo E., Porsteinsson, Anton P., Schneider, Lon S., Weintraub, Daniel, Yesavage, Jerome, Shade, David M., Lyketsos, Constantine G.
Publicado en J Pharmacokinet Pharmacodyn (2015)

Sertraline for the treatment of depression in Alzheimer’s disease: Week-24 outcomes

por Weintraub, Daniel, Rosenberg, Paul B., Drye, Lea T., Martin, Barbara K., Frangakis, Constantine, Mintzer, Jacobo E., Porsteinsson, Anton P., Schneider, Lon S., Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Lyketsos, Constantine G.
Publicado 2010

Sertraline for the treatment of depression in Alzheimer’s disease

por Rosenberg, Paul B., Drye, Lea T., Martin, Barbara K., Frangakis, Constantine, Mintzer, Jacobo E., Weintraub, Daniel, Porsteinsson, Anton P., Schneider, Lon S., Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Lyketsos, Constantine G.
Publicado 2010

Do treatment effects vary among differing baseline depression criteria in Depression in Alzheimer’s Disease Study – 2 (DIADS-2)?

por Drye, Lea T., Martin, Barbara K., Frangakis, Constantine E., Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Weintraub, Daniel, Lyketsos, Constantine G.
Publicado 2011

Cognitive Outcomes after Sertaline Treatment in Patients with Depression of Alzheimer’s Disease

por Munro, Cynthia A., Longmire, Crystal Flynn, Drye, Lea T., Martin, Barbara K., Frangakis, Constantine E., Meinert, Curtis L., Mintzer, Jacobo E., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Weintraub, Daniel, Lyketsos, Constantine G.
Publicado 2012

Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences

por Peters, Matthew E., Vaidya, Vijay, Drye, Lea T., Devanand, Davangere P., Mintzer, Jacobo E., Pollock, Bruce G., Porsteinsson, Anton P., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G., Avramopoulos, Dimitri
Publicado en J Geriatr Psychiatry Neurol (2015)

Is sertraline treatment or depression remission in depressed Alzheimer’s patients associated with improved caregiver wellbeing? The Depression in Alzheimer’s Disease Study 2 (DIADS...

por Longmire, Crystal V. Flynn, Drye, Lea T., Frangakis, Constantine E., Martin, Barbara K., Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Weintraub, Daniel, Lyketsos, Constantine G.
Publicado 2014

Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer’s Disease

por Tao, Ye, Peters, Matthew E., Drye, Lea T., Devanand, Davangere P., Mintzer, Jacobo E., Pollock, Bruce G., Porsteinsson, Anton P., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G., Munro, Cynthia A.
Publicado en Am J Alzheimers Dis Other Demen (2018)

R‐ and S‐citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation

por Ho, Thang, Pollock, Bruce G., Mulsant, Benoit H., Schantz, Oliver, Devanand, Devangere P., Mintzer, Jacobo E., Porsteinsson, Anton P., Schneider, Lon S., Weintraub, Daniel, Yesavage, Jerome, Drye, Lea T., Munro, Cynthia A., Shade, David M., Lyketsos, Constantine, Bies, Robert
Publicado en Br J Clin Pharmacol (2016)

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate

por van Dyck, Christopher H., Arnsten, Amy F.T., Padala, Prasad R., Brawman-Mintzer, Olga, Lerner, Alan J., Porsteinsson, Anton P., Scherer, Roberta W., Levey, Allan I., Herrmann, Nathan, Jamil, Nimra, Mintzer, Jacobo E., Lanctôt, Krista L., Rosenberg, Paul B.
Publicado en Am J Geriatr Psychiatry (2020)

Citalopram for agitation in Alzheimer’s disease (CitAD): design and methods

por Drye, Lea T., Ismail, Zahinoor, Porsteinsson, Anton P., Rosenberg, Paul B., Weintraub, Daniel, Marano, Christopher, Pelton, Gregory, Frangakis, Constantine, Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Devanand, D.P., Yesavage, Jerome, Mintzer, Jacobo E., Schneider, Lon S., Pollock, Bruce G., Lyketsos, Constantine G.
Publicado 2012

Measuring apathy in Alzheimer’s disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): a comparison of instruments

por Lanctôt, Krista L., Scherer, Roberta W., Li, Abby, Vieira, Danielle, Coulibaly, Hamadou, Rosenberg, Paul B., Herrmann, Nathan, Lerner, Alan J, Padala, Prasad R, Brawman-Mintzer, Olga, van Dyck, Chris H., Porsteinsson, Anton P., Craft, Suzanne, Levey, Allan, Burke, William J, Mintzer, Jacobo E.
Publicado en Am J Geriatr Psychiatry (2020)

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

por Drye, Lea T., Spragg, David, Devanand, D. P., Frangakis, Constantine, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Pollock, Bruce G., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado 2014

Effect of Citalopram on Agitation in Alzheimer's Disease – The CitAD Randomized Controlled Trial

por Porsteinsson, Anton P., Drye, Lea T., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado 2014